• Founded: 2014
  • Location: Durham, NC
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Undisclosed
  • Lead product: Undisclosed
  • Product link: https://ribometrix.com/platform/
  • Funding: $30M A Nov 2018
  • Investors: Amgen



job board

Short description:

Small molecule drugs that target functional 3D RNA structures to treat human diseases.

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

Ribometrix is discovering novel small molecular medicines that target RNA structure to treat human diseases. The vast majority of drugs are designed to target disease-driving proteins. Instead, Ribometrix is identifying therapeutic drugs that target disease-causing RNAs that downstream could be used to make proteins or the RNAs can have a regulatory role in disease progression. Drugging RNA is now possible due to technologies developed by Ribometrix that enable them to discover the 3D structure of RNA. By analyzing these structures, Ribometrix has uncovered that RNAs contain many clefts and crevices which can be bound by small molecule drugs, modulating the function of the RNA. Ribometrix is collaborating with Genentech to commercialize therapeutic candidates.


Office Mgr/Executive Assistant
Durham, NC|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com